Data Insights
                                    By  Company Name
                                
                                No Filter Selected
                                    By  Disease Name
                                
                                No Filter Selected
                                    By  Drug Name
                                
                                No Filter Selected
                                    By Themes
                                
                                No Filter Selected
                                    Showing 2 results out of 2                                
                                
                                                Data Insights
                                                
                                        AGN-193408 SR by AbbVie for Ocular Hypertension: Likelihood of Approval
AGN-193408 SR is under clinical development by AbbVie and currently in Phase II for Ocular Hypertension. According to GlobalData, Phase...
                                                Data Insights
                                                
                                        AGN-193408 SR by AbbVie for Open-Angle Glaucoma: Likelihood of Approval
AGN-193408 SR is under clinical development by AbbVie and currently in Phase II for Open-Angle Glaucoma. According to GlobalData, Phase...